VBI Vaccines - 19 Year Dividend History | VBIV
Historical dividend payout and yield for VBI Vaccines (VBIV) since 2005. The current TTM dividend payout for VBI Vaccines (VBIV) as of April 25, 2024 is $0.00. The current dividend yield for VBI Vaccines as of April 25, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.017B |
$0.009B |
|
VBI Vaccines Inc. is a biopharmaceutical company developing novel technologies to expand vaccine protection. The company's eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines which closely mimic the target virus. Its lead eVLP asset is a prophylactic cytomegalovirus vaccine. Its second platform is a thermostable technology that enables the development of vaccines and biologics. VBI Vaccines Inc., formerly known as SciVac Therapeutics, Inc., is headquartered in Cambridge, MA.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
